BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6381253)

  • 1. Studies on the binding of complement factor C3 to the surface of human blood platelets.
    Endresen GK; Mellbye OJ
    Haemostasis; 1984; 14(3):269-80. PubMed ID: 6381253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-bound complement (C3) in immune thrombocytopenia.
    Hauch TW; Rosse WF
    Blood; 1977 Dec; 50(6):1129-36. PubMed ID: 562691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the binding of immunoglobulins and immune complexes to the surface of human platelets: IgG molecules react with platelet Fc receptors with the CH3 domain.
    Endresen GK; Førre O
    Int Arch Allergy Appl Immunol; 1982; 67(1):33-9. PubMed ID: 6799409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement (C3) binding to platelets in autoimmune thrombocytopenia.
    Kernoff LM; Malan E
    Clin Lab Haematol; 1983; 5(1):1-7. PubMed ID: 6682732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous enzymo-immunologic assays of platelet associated IgG, IgM and C3. A useful tool in assessment of immune thrombocytopenias.
    Follea G; Mandrand B; Dechavanne M
    Thromb Res; 1982 May; 26(4):249-58. PubMed ID: 7051415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method for the simultaneous quantitation of platelet-bound immunoglobuin (IgG) and complement (C3) employing an enzyme-linked immunosorbent assay (ELISA) procedure.
    Nel JD; Stevens K
    Br J Haematol; 1980 Feb; 44(2):281-90. PubMed ID: 7189662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the indirect platelet radioactive antiglobulin test with anti-IgG and anti-C3 in immune and nonimmune thrombocytopenias.
    Freedman J; Cheong T; Garvey MB
    Am J Hematol; 1985 Mar; 18(3):297-305. PubMed ID: 3883754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixation of C3 to platelets in vitro by antiplatelet antibody from patients with immune thrombocytopenic purpura.
    McMillan R; Martin M
    Br J Haematol; 1981 Feb; 47(2):251-6. PubMed ID: 7193475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet antibodies of the IgM class in immune thrombocytopenic purpura.
    Cines DB; Wilson SB; Tomaski A; Schreiber AD
    J Clin Invest; 1985 Apr; 75(4):1183-90. PubMed ID: 4039335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
    Ekdahl KN; Nilsson B
    J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans.
    Halkjær L; Troldborg A; Pedersen H; Jensen L; Hansen AG; Hansen TK; Bjerre M; Østergaard JA; Thiel S
    Front Immunol; 2020; 11():774. PubMed ID: 32431705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose intravenous IgG reduces platelet associated immunoglobulins and complement in idiopathic thrombocytopenic purpura.
    Winiarski J; Kreuger A; Ejderhamn J; Holm G
    Scand J Haematol; 1983 Oct; 31(4):342-8. PubMed ID: 6312557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of positive control platelets for detection of canine platelet surface-associated IgG, IgM and complement (C3) by flow cytometry.
    Tsuchiya R; Komatsu T; Ishikawa T; Neo S; McConnell MF; Hisasue M; Yamada T
    J Vet Med Sci; 2010 Aug; 72(8):1063-6. PubMed ID: 20234115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet antibodies in idiopathic thrombocytopenic purpura.
    Veenhoven WA; Van der Schans GS; Nieweg HO
    Clin Exp Immunol; 1980 Mar; 39(3):645-51. PubMed ID: 6991171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked immunosorbent assay (ELISA) for direct quantification of surface-bound platelet immunoglobulins.
    Hansen OP; Overballe C; Hippe E
    Scand J Clin Lab Invest; 1983 Oct; 43(6):513-9. PubMed ID: 6229025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of a novel low affinity complement C3dg-binding protein of human platelets.
    Chen H; Marjan J; Cox AD; Devine DV
    J Immunol; 1994 Feb; 152(3):1332-8. PubMed ID: 8301135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response.
    Dixon R; Rosse W; Ebbert L
    N Engl J Med; 1975 Jan; 292(5):230-6. PubMed ID: 1078594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
    Iida K; Mitomo K; Fujita T; Tamura N
    J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.